ReposiTrak reported an EPS of $0.08, slightly below the estimated $0.09 but exceeded revenue expectations with $5.9 million.The company saw a 7% increase in total revenue, reaching $5.9 million up from $5.5 million the previous year.TRAK's financial health is solid with a P/E ratio of approximately 25.36, a low debt-to-equity ratio of 0.008, and a current ratio of approximately 5.45.ReposiTrak, Inc. (NYSE:TRAK) is a leading player in the food traceability and regulatory compliance sector. The company is kno ...

Core Insights - ReposiTrak (NYSE: TRAK) is a leader in the food traceability and regulatory compliance sector, focusing on food safety and compliance with regulations [1] Financial Performance - On September 29, 2025, TRAK reported an earnings per share (EPS) of $0.09, matching estimates, but revenue was $5.76 million, below the expected $6.25 million [2][6] - Full-year revenue increased by 11% to $22.6 million, indicating a positive trend year-over-year [2][6] - Net income for the fiscal year rose by 17% to $7 million, showcasing strong financial health [3][6] Revenue Composition - TRAK's recurring revenue constitutes about 99% of total revenue, indicating a stable income stream [3] Valuation Metrics - The price-to-earnings (P/E) ratio is approximately 44.72, suggesting high investor confidence [4] - The price-to-sales ratio is around 13.74, and the enterprise value to sales ratio is about 12.50, reflecting strong sales performance [4] Liquidity and Financial Ratios - TRAK has a current ratio of about 6.03, indicating a robust ability to cover short-term liabilities [5] - The enterprise value to operating cash flow ratio is approximately 31.22, and the earnings yield is around 2.24%, providing insights into valuation and return on investment [5]